Margaret Koziel - 01 Mar 2022 Form 4 Insider Report for Axcella Health Inc.

Signature
By: /s/ Paul Fehlner, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Mar 2022
Net transactions value
-$1,030
Form type
4
Filing time
03 Mar 2022, 15:19:08 UTC
Previous filing
10 Feb 2022
Next filing
02 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXLA Common Stock Sale $1,030 -553 -2% $1.86* 26,699 01 Mar 2022 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"), and does not represent a discretionary trade by the reporting person.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.86 to $1.87. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 The Form 3 filed by the reporting person on December 13, 2021 inadvertently overstated the number of securities beneficially owned by 2,748 shares in Table I, Column 2.
F4 Includes RSUs. Each RSU represents a contingent right to receive one share of AXLA common stock.